|
|
Orthovita, Inc. - Earning & Dividend Analysis Snapshot
This detailed Report provides an Earnings and Dividends history for Orthovita, Inc.. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.
Orthovita, Inc.. The Group's principal activity is to develop, manufacture and market synthetic bone substitutes for orthopaedic applications that are useful in spine and joint replacements. The Group develops and markets synthetic-based biomaterial products for use in spine surgery, the repair of osteoporotic fractures, and a range of clinical needs in the trauma, joint reconstruction, revision and extremities markets. The products are based on two platforms: The products include VITOSS Bone Graft Substitute technology platforms, which are designed to address the non-structural, bone-graft market and VITAGEL Surgical Hemostat, which is a matrix for soft-tissue healing.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|